Guardant Health
GH
#1530
Rank
S$17.59 B
Marketcap
S$135.45
Share price
2.33%
Change (1 day)
177.68%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$2.11 Billion

According to Guardant Health 's latest financial reports the company's total liabilities are S$2.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$2.20 B2.76%
2023-12-31S$2.14 B3.47%
2022-12-31S$2.07 B-1.45%
2021-12-31S$2.10 B73.94%
2020-12-31S$1.21 B684.89%
2019-12-31S$0.15 B81%
2018-12-31S$85.31 M85.8%
2017-12-31S$45.91 M-13.95%
2016-12-31S$53.36 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Natera
NTRA
S$0.73 B-65.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
S$1.63 B-22.79%๐Ÿ‡บ๐Ÿ‡ธ USA